Anthropic's expansion into science tooling and drug discovery is raising enterprise competition concerns among clients who worry the AI vendor may become a competitor. The concerns, reported by BetaKi…
Anthropic announced a new science-focused AI model and plans to develop drugs itself, prompting Palantir's Alex Karp and others to warn enterprises that the company could become a competitor after acc…
Novo Nordisk, a Danish pharmaceutical company, struggles to measure the return on investment of generative AI due to complex, multi-step drug development processes. The company uses AI-powered digital…
Bernstein raised its price target for ASML to $2,623, implying 48% upside, despite the stock more than doubling in the past year. The Dutch semiconductor equipment maker is Europe's most valuable comp…
Microsoft announced Microsoft Frontier Company, a new operating business focused on AI-driven transformation, backed by a $2.5 billion investment and 6,000 industry and engineering experts. The compan…
Microsoft launched Microsoft Frontier Company, a new business unit dedicated to AI-driven enterprise transformation, backed by a $2.5 billion investment and 6,000 embedded experts. The unit combines i…
Eli Lilly invested $40 million in Absci, a generative AI drug company, to develop ABS-201, an injectable antibody for baldness and endometriosis. The deal, part of a $100 million stock offering, aims …
European companies ASML, Novo Nordisk, and Mistral have achieved global leadership in advanced chips, obesity drugs, and open-source AI despite a venture capital pool 75% smaller than the US and €700 …
Space X was the most bought stock on Swedish online brokers Avanza and Nordnet in June, driven by AI and space interest. Avanza customers sold Sivers Semiconductors for the fourth consecutive month, t…
Nordic stock exchanges fell on Tuesday, led by declines in technology and AI-related stocks. Oslo's OBX index dropped 0.1%, with Norsk Hydro falling 3.8% and Nordic Semiconductor down 4.7%. Copenhagen…
Nadia Carlsten, former AWS executive, became CEO of Smartbird (formerly Allbirds) after the company pivoted to AI infrastructure, selling its shoe business for $43 million and raising $100 million. Sm…
Cyber extortion group FulcrumSec claimed on Tuesday to have stolen over a terabyte of data from pharmaceutical giant Novo Nordisk and attempted a $25 million extortion. The group said it is now explor…
GLP-1 drug use peaks in middle age, with 22% of adults aged 50-64 taking them, then drops sharply to 9% at age 65 due to Medicare's ban on covering weight-loss medications. The overall adult usage rat…
AI systems are fundamentally code and cannot be made smarter through prompting alone, as demonstrated by bots that uncritically accept any input. The article highlights the limitations of current AI, …
Cellular Intelligence, an AI-native biotech, acquired global rights to STEM-PD, a Phase 2-ready cell therapy for Parkinson's disease, from Novo Nordisk. Novo Nordisk shuttered its cell therapy unit in…
Novo Nordisk disclosed a cyberattack on its systems, with the company investigating the incident and working to contain the breach. The announcement came as the UK’s medicines regulator granted approv…
Eric Ries, author of *The Lean Startup*, released a new book titled *Incorruptible* that examines why successful companies become corrupted into mediocrity and how governance structures can protect th…